Copyright
©The Author(s) 2015.
World J Gastroenterol. Dec 28, 2015; 21(48): 13490-13499
Published online Dec 28, 2015. doi: 10.3748/wjg.v21.i48.13490
Published online Dec 28, 2015. doi: 10.3748/wjg.v21.i48.13490
Table 3 Risk factor of intrahepatic distant recurrence in the CyberKnife® group
| CyberKnife® | |||
| Distant recurrence (-) | Distant recurrence (+) | P value | |
| n | 28 | 7 | |
| Tumor size (mm) | 26.6 ± 11.1 | 36.3 ± 10.6 | 0.045 |
| Total dose (Gy) | 50.6 ± 7.8 | 43.6 ± 6.7 | 0.036 |
- Citation: Shiozawa K, Watanabe M, Ikehara T, Matsukiyo Y, Kogame M, Kishimoto Y, Okubo Y, Makino H, Tsukamoto N, Igarashi Y, Sumino Y. Comparison of percutaneous radiofrequency ablation and CyberKnife® for initial solitary hepatocellular carcinoma: A pilot study. World J Gastroenterol 2015; 21(48): 13490-13499
- URL: https://www.wjgnet.com/1007-9327/full/v21/i48/13490.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i48.13490